Skip to main content
ConductScienceScienceDex

Johannes F Fahrmann

NIH Rank #8019
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14158591Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$1.8M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#8,019
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Johannes F Fahrmann. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Johannes F Fahrmann as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA282216-03U01
    Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
    UT MD Anderson Cancer Center
    $672.3K
    award amount
  • 1R01CA299972-01R01
    Deregulation of Sulfatide Synthesis in the Development and Progression of Pancreatic Cancer Precursor Lesions
    UT MD Anderson Cancer Center
    $616.5K
    award amount
  • 5R37CA269611-03R37
    Repurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer
    UT MD Anderson Cancer Center
    $480.2K
    award amount

Award organization

Organizations that administered FY2025 awards listing Johannes F Fahrmann as a PI.

FY2025 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #8019
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader

Explore further

Find collaborators for Johannes F Fahrmann

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →